| LDR | | 00000cam u2200205 a 4500 |
| 001 | | 000014037844 |
| 005 | | 20230227110748 |
| 006 | | m d |
| 007 | | cr cn||||||||| |
| 008 | | 220702s2022 dcua ob 100 0 eng |
| 020 | |
▼a 9780309686778
▼q (electronic bk.) |
| 020 | |
▼a 0309686776 |
| 020 | |
▼z 9780309686761 |
| 020 | |
▼z 0309686768 |
| 035 | |
▼a 3301665
▼b (N$T) |
| 035 | |
▼a (OCoLC)1328956458 |
| 040 | |
▼a NLM
▼b eng
▼c NLM
▼d SNM
▼d 224010
▼d RBN
▼d N$T
▼e rda
▼e pn |
| 042 | |
▼a pcc |
| 050 | 4 |
▼a RC271.H45 |
| 060 | 00 |
▼a WH 383 |
| 082 | 04 |
▼a 617.9/54
▼2 22 |
| 090 | |
▼a 617.954 |
| 100 | 1 |
▼a Denning, Laura Aiuppa,
▼e rapporteur. |
| 245 | 10 |
▼a Exploring the state of the science of stem cell transplantation and posttransplant disability
▼h [electronic resource]:
▼b proceedings of a workshop /
▼c Laura Aiuppa Denning and Erin Hammers Forstag, rapporteurs ; Board on Health Care Services, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. |
| 260 | |
▼a Washington, DC:
▼b National Academies Press,
▼c [2022] |
| 300 | |
▼a 1 online resource (1 PDF file (xvi, 92 pages)) :
▼b illustrations |
| 336 | |
▼a text
▼b txt
▼2 rdacontent |
| 337 | |
▼a computer
▼b c
▼2 rdamedia |
| 338 | |
▼a online resource
▼b cr
▼2 rdacarrier |
| 504 | |
▼a Includes bibliographical references. |
| 520 | 3 |
▼a The Board on Health Care Services of the National Academies of Sciences, Engineering and Medicine hosted a virtual workshop, funded by the Social Security Association, to examine disability associated with hematopoietic stem cell transplantation. The workshop, held on November 15, 2021, included presentations on the functional outcomes for individuals who have received hematopoietic stem cell treatment, as well as medical advances, developments, and research in this area. This Proceedings of a Workshop highlights the presentations and discussions that occurred in the workshop. |
| 536 | |
▼a This activity was supported by a contract between the National Academy of Sciences and the U.S. Social Security Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. |
| 650 | 12 |
▼a Hematopoietic Stem Cell Transplantation. |
| 650 | 22 |
▼a Hematopoietic Stem Cell Transplantation
▼x adverse effects. |
| 650 | 22 |
▼a Health Services for Persons with Disabilities. |
| 650 | 0 |
▼a Hematopoietic stem cells
▼x Transplantation. |
| 651 | 2 |
▼a United States. |
| 655 | 2 |
▼a Congress. |
| 700 | 1 |
▼a Forstag, Erin Hammers,
▼e rapporteur. |
| 710 | 2 |
▼a National Academies of Sciences, Engineering, and Medicine (U.S.).
▼b Board on Health Care Services,
▼e issuing body,
▼e host institution. |
| 711 | 2 |
▼a State of Science of Hematopoietic Stem Cell Treatment and Disability (Workshop)
▼d (2021 :
▼c Online) |
| 856 | 40 |
▼3 EBSCOhost
▼u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3301665 |